Skip to main navigation Skip to search Skip to main content

SARS-CoV-2 in companion animals: Do levels of SARS-CoV-2 seroconversion in pets correlate with those of pet’s owners and with protection against subsequent SARS-CoV-2 infection?

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)1216-1220
Number of pages5
JournalVirulence
Volume13
Issue number1
DOIs
StatePublished - 2022

Bibliographical note

Funding Information:
This work was supported in part by seed funds from the University of Minnesota Office of Clinical and Academic Affairs’ COVID-19 rapid response mechanism to H.M., M.M.R., D.D., M.D., Y.L., and H.L. H.M. and S.S. were supported in part by the Minnesota Drive Global Food Ventures (MnDRIVE GFV) Graduate Professional Development Program. H.M. was supported in part by the NIH T32 Virology Training Grant AI083196 and by the J.B. and J.N. Moe Graduate Fellowship. S.S. was supported in part by the S. Maheswaran Graduate Fellowship and by the B. Pomeroy Legacy Scholarship. The authors would like to thank K. Little, T. Ruska, and L. Kranz (MN Veterinary Clinical Pathology Laboratory) for collecting and preparing discarded serum samples from pets for this study.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • ELISA
  • Minnesota
  • SARS-CoV-2
  • canines
  • felines
  • seroprevalence

Cite this